S. Korea to approve Viagra generics

March 14, 2012

Three South Korean pharmaceutical firms will soon be allowed to produce generic versions of the anti-impotence drug Viagra despite a row over patents, officials said Wednesday.

The Korea said generic products made by the three local firms have passed a "bioequivalence" test.

"The three firms are expected to get approval for production of Viagra generics probably this month or later," an official in charge of medicine tests told AFP on condition of anonymity.

"Our move has nothing to do with an ongoing patent row," he said, adding the watchdog is also expected to give the go ahead for more local firms.

Numerous domestic pharmaceutical firms have applied for approval to manufacture Viagra generics since it was introduced in in 1999.

US pharmaceutical giant Pfizer claims its patent, which involves using sildenafil, is valid until May 2014.

"Our patent covering the material is still valid," a Pfizer official in Seoul said, urging South Korean firms to recognise it.

Pfizer has yet to counter a lawsuit filed by CJ Cheiljedang, a domestic seeking to invalidate the patent.

"We plan to produce a generic Viagra regardless of the court's ruling, even if we have to compensate Pfizer in the future," an unnamed CJ Cheiljedang official told Yonhap news agency.

Explore further: Drug firm GSK fined $2.6 million for collusion

Related Stories

Drug firm GSK fined $2.6 million for collusion

October 24, 2011

South Korea's anti-trust agency has fined drugmaker GlaxoSmithKline three billion won ($2.6 million) for conspiring with a Seoul rival over the sale of drugs, an official said Monday.

India patent case threatens cheap drug supply: MSF

September 5, 2011

Supply of cheap, copycat drugs for the developing world could be badly threatened if Swiss firm Novartis wins a challenge to India's patent law, medical charity MSF said on Monday.

Recommended for you

CVS generic competitor to EpiPen, sold at a 6th the price

January 12, 2017

CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy treatment was eviscerated before Congress because of its soaring cost to ...

Many misuse OTC sleep aids: survey

December 29, 2016

(HealthDay)—People struggling with insomnia often turn to non-prescription sleep remedies that may be habit-forming and are only intended for short-term use, according to a new Consumer Reports survey.

The pill won't kill your sexual desire, researchers say

December 15, 2016

Taking the pill doesn't lower your sexual desire, contrary to popular belief, according to research published in the Journal of Sexual Medicine. The authors of the research, from the University of Kentucky and Indiana University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.